GlassScriptPhysician profile
Florencio Singson
NPI 1386694867
$1,219.83
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $267 · 2021: $66.86 · 2022: $13.14.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $264.89 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $194.54 | 2019-2020 | |
| Radius Health, INC. | $125.03 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.46 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $92.21 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.60 | 2019 | |
| Pfizer INC. | $63.18 | 2019 | |
| Sanofi-Aventis U.S. LLC | $59.25 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $57.92 | 2019 | |
| Ironshore Pharmaceuticals INC. | $42.98 | 2020-2021 | |
| Novo Nordisk INC | $41.75 | 2019 | |
| Glaxosmithkline, LLC. | $26.71 | 2019 | |
| Lilly USA, LLC | $26.65 | 2019 | |
| Orexo US, INC. | $13.52 | 2020 | |
| Avanir Pharmaceuticals, INC. | $13.14 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florencio Singson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.